Preventing Anthracycline-Associated Heart Failure: What Is the Role of Dexrazoxane?

被引:7
作者
Zheng, Haoyi [1 ]
Zhan, Huichun [2 ,3 ]
机构
[1] St Francis Hosp, Heart Ctr, 100 Port Washington Blvd, Roslyn, NY 11576 USA
[2] SUNY Stony Brook, Dept Med, Sch Med, Stony Brook, NY USA
[3] Northport VA Med Ctr, Med Serv, Northport, NY USA
来源
JACC: CARDIOONCOLOGY | 2024年 / 6卷 / 02期
关键词
anthracycline; cardiotoxicity; dexrazoxane; heart failure; statin; CARDIOPROTECTION; DOXORUBICIN; CANCER;
D O I
10.1016/j.jaccao.2024.01.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:318 / 321
页数:4
相关论文
共 11 条
  • [1] Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines
    de Baat, Esmee C.
    Mulder, Renee L.
    Armenian, Saro
    Feijen, Elizabeth A. M.
    Grotenhuis, Heynric
    Hudson, Melissa M.
    Mavinkurve-Groothuis, Annelies M. C.
    Kremer, Leontien C. M.
    van Dalen, Elvira C.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (09):
  • [2] Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA) Extended Follow-Up of a 2x2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol
    Heck, Siri Lagethon
    Mecinaj, Albulena
    Ree, Anne Hansen
    Hoffmann, Pavel
    Schulz-Menger, Jeanette
    Fagerland, Morten Wang
    Gravdehaug, Berit
    Rosjo, Helge
    Steine, Kjetil
    Geisler, Juergen
    Gulati, Geeta
    Omland, Torbjorn
    [J]. CIRCULATION, 2021, 143 (25) : 2431 - 2440
  • [3] Hundley W Gregory, 2022, NEJM Evid, V1, DOI 10.1056/evidoa2200097
  • [4] ESC 2022 guidelines on cardio-oncology in collaboration with the European Hematology Association (EHA), European Society of Therapeutic Radiology and Oncology (ESTRO) and International Cardio-Oncology Society (IC- OS) developed by the Cardio-Oncology Task Force of the European Society of Cardiology (ESC)
    Lyon, Alexander R.
    Lopez-Fernandez, Teresa
    Couch, Liam S.
    Asteggiano, Riccardo
    Aznar, Marianne C.
    Bergler-Klein, Jutta
    Boriani, Giuseppe
    Cardinale, Daniela
    Cordoba, Raul
    Cosyns, Bernard
    Cutter, David J.
    de Azambuja, Evandro
    de Boer, Rudolf A.
    Dent, Susan F.
    Farmakis, Dimitrios
    Gevaert, Sofie A.
    Gorog, Diana A.
    Herrmann, Joerg
    Lenihan, Daniel
    Moslehi, Javid
    Moura, Brenda
    Salinger, Sonja S.
    Stephens, Richard
    Suter, Thomas M.
    Szmit, Sebastian
    Tamargo, Juan
    Thavendiranathan, Paaladinesh
    Tocchetti, Carlo G.
    van der Meer, Peter
    van der Pal, Helena J. H.
    [J]. GIORNALE ITALIANO DI CARDIOLOGIA, 2023, 24 (02) : E1 - E130
  • [5] McMurray JJV, 2002, EUR HEART J SUPPL, V4, pD50, DOI 10.1016/S1520-765X(02)90160-4
  • [6] Atorvastatin for Anthracycline-Associated Cardiac Dysfunction The STOP-CA Randomized Clinical Trial
    Neilan, Tomas G.
    Quinaglia, Thiago
    Onoue, Takeshi
    Mahmood, Syed S.
    Drobni, Zsofia D.
    Gilman, Hannah K.
    Smith, Amanda
    Heemelaar, Julius C.
    Brahmbhatt, Priya
    Ho, Jor Sam
    Sama, Supraja
    Svoboda, Jakub
    Neuberg, Donna S.
    Abramson, Jeremy S.
    Hochberg, Ephraim P.
    Barnes, Jefferey A.
    Armand, Philippe
    Jacobsen, Eric D.
    Jacobson, Caron A.
    Kim, Austin I.
    Soumerai, Jacob D.
    Han, Yuchi
    Friedman, Robb S.
    Lacasce, Ann S.
    Ky, Bonnie
    Landsburg, Dan
    Nasta, Sunita
    Kwong, Raymond Y.
    Jerosch-Herold, Michael
    Redd, Robert A.
    Hua, Lanqi
    Januzzi, James L.
    Asnani, Aarti
    Mousavi, Negareh
    Scherrer-Crosbie, Marielle
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (06): : 528 - 536
  • [7] Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group
    Schwartz, Cindy L.
    Wexler, Leonard H.
    Krailo, Mark D.
    Teot, Lisa A.
    Devidas, Meenakshi
    Steinherz, Laurel J.
    Goorin, Allen M.
    Gebhardt, Mark C.
    Healey, John H.
    Sato, Judith K.
    Meyers, Paul A.
    Grier, Holcombe E.
    Bernstein, Mark L.
    Lipshultz, Steven E.
    [J]. PEDIATRIC BLOOD & CANCER, 2016, 63 (01) : 54 - 61
  • [8] Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy
    Swain, SM
    Whaley, FS
    Gerber, MC
    Ewer, MS
    Bianchine, JR
    Gams, RA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) : 1333 - 1340
  • [9] Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer
    Swain, SM
    Whaley, FS
    Gerber, MC
    Weisberg, S
    York, M
    Spicer, D
    Jones, SE
    Wadler, S
    Desai, A
    Vogel, C
    Speyer, J
    Mittelman, A
    Reddy, S
    Pendergrass, K
    VelezGarcia, E
    Ewer, MS
    Bianchine, JR
    Gams, RA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) : 1318 - 1332
  • [10] Congestive heart failure in patients treated with doxorubicin - A retrospective analysis of three trials
    Swain, SM
    Whaley, FS
    Ewer, MS
    [J]. CANCER, 2003, 97 (11) : 2869 - 2879